Metraipolis › archive › dc_ef318b1cd797

Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide… — Europe PMC PMID:41469663

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41469663
DOI
10.1186/s12933-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-07T07:21:27.731Z
SHA-256 of the archived text
23c69abd0855be4a4713e4fd540edb0eb7702981b37f7c2045fe81027de0ffdd
Stable URL of this page
https://metraipolis.com/documento/dc_ef318b1cd797

How to cite

Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide… — Europe PMC PMID:41469663 — Europe PMC (en), https://europepmc.org/article/MED/41469663 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef318b1cd797 (Metraipolis archive dc_ef318b1cd797, sha256 23c69abd0855be4a4713e4fd540edb0eb7702981b37f7c2045fe81027de0ffdd)
BibTeX
@misc{dcef318b1cd797,
  title = {Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide… — Europe PMC PMID:41469663},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41469663},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef318b1cd797; sha256 23c69abd0855be4a4713e4fd540edb0eb7702981b37f7c2045fe81027de0ffdd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41469663. Agents can read the archived copy with the MCP tool read_document.